Gengraf (AbbVie Inc.)


Welcome to the PulseAid listing for the Gengraf drug offered from AbbVie Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AbbVie Inc.
NON-PROPRIETARY NAME: Cyclosporine
SUBSTANCE NAME: CYCLOSPORINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00


Gengraf HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGengraf from AbbVie Inc.
LABELER NAME: AbbVie Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 2016-06-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0074-0541_0d2f89e8-9e48-22ba-bf5e-a20c6c227664
PRODUCT NDC: 0074-0541
APPLICATION NUMBER: ANDA065003

Other CYCLOSPORINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Gengraf
Actavis Pharma, Inc.CycloSPORINE
Allergan, Inc.Restasis MultiDose
American Health PackagingCyclosporine
Apotex Corp.Cyclosporine
Cardinal HealthCyclosporine
DR MARC’S MANUFACTURING AND SALESCYCLO-DERM
Eon Labs, Inc.Cyclosporine
IVAX Pharmaceuticals, Inc.Cyclosporine
Mayne Pharma Inc.Cyclosporine
Novartis Pharmaceuticals CorporationSandimmune
Perrigo CompanyCyclosporine
Physicians Total Care, Inc.RESTASIS
Teva Pharmaceuticals USA IncCyclosporine